CFD
ITRM

Creative Financial Designs’s Iterum Therapeutics ITRM Stock Holding History

Creative Financial Designs’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,047
Closed -$75.7K – 2093
2025
Q2 		$75.7K Buy
76,047
+6,100
+9% +$6.36K 0.01% 743
2025
Q1 		$86K Buy
69,947
+10,047
+17% +$14.9K 0.01% 659
2024
Q4 		$106K Buy
+59,900
New +$93.9K 0.01% 591
2023
Q1 		– Sell
-200
Closed -$168 – 1421
2022
Q4 		$168 Sell
200
-1,000
-83% -$1.42K ﹤0.01% 1273
2022
Q3 		$2K Buy
1,200
+667
+125% +$2.02K ﹤0.01% 1169
2022
Q2 		$2K Buy
+533
New +$1.99K ﹤0.01% 1126

Other funds holding ITRM

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Creative Financial Designs's ITRM Position: Q3 2025 in Review

Creative Financial Designs sold out of Iterum Therapeutics (ITRM) in Q3 2025, closing a stake of 76,047 shares — an estimated $75.7K sold.

Creative Financial Designs first reported a position in ITRM in Q2 2022 and held it in 6 quarters. The position peaked at $106K in Q4 2024. 24 funds tracked by Wall St. Rank hold ITRM as of Q3 2025.

  • Creative Financial Designs reported no remaining Iterum Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Creative Financial Designs sold 76,047 Iterum Therapeutics shares in Q3 2025, an estimated $75.7K.
  • Creative Financial Designs first reported a position in Iterum Therapeutics in Q2 2022 and held it in 6 quarters.
  • Creative Financial Designs's Iterum Therapeutics position peaked at $106K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2025.

Based on Creative Financial Designs's 13F filing for Q3 2025, filed 12 Nov 2025.